Insiders Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
0.7725 ^USD	-0.96%		-2.31%	-30.41%

24/06	CytoSorbents' Blood Purification Device Gets Approval in Taiwan	MT
24/06	CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytosorbents Reappoints Kathleen Bloch as Finance Chief	19/23/19	MT
Cytosorbents Reports Resignation of CFO D'Amico	02/23/02	MT
Cytosorbents Corporation Announces Resignation of Alexander D?Amico as Chief Financial Officer, Effective August 28, 2023	02/23/02	CI
Cytosorbents Names Alexander D'Amico CFO	19/23/19	MT
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial	08/23/08	CI
Cytosorbents Corporation Announces Retirement of Al W. Kraus as A Member of Board	20/23/20	CI
Cytosorbents Corporation Appoints Irina B. Kulinets as Senior Vice President of Global Regulatory Affairs	17/23/17	CI
Cytosorbents Chief Financial Officer Kathleen Bloch to Retire in March	07/22/07	MT
Cytosorbents Corporation Hires Shaun Whittemore as Country Manager - UK & Ireland	15/22/15	CI
Cytosorbents Corporation Appoints Jiny Kim to its Board of Directors	05/22/05	CI
CytoSorbents Corporation Appoints Terri Anne Powers as Vice President of Investor Relations and Corporate Communications	01/21/01	CI
Cytosorbents Corporation Appoints James Komsa as Vice President – U.S. Sales and Marketing	05/21/05	CI
Cytosorbents Corporation Appoints David D. Cox, Ph.D., M.B.A. as Vice President - Global Regulatory Affairs	21/21/21	CI
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing	17/20/17	CI
CytoSorbents Promotes Vincent J. Capponi to President and COO	04/20/04	CI
CytoSorbents Corporation Appoints Efthymios N. Deliargyris as Chief Medical Officer, Effective on May 1, 2020	27/20/27	CI
Cytosorbents Corporation Announces Resignation of Eric Mortensen as Chief Medical Officer, Effective December 31, 2019	13/19/13	CI
Eric Mortensen, Chief Medical Officer, to Leave Cytosorbents Corporation	07/19/07	CI
Cytosorbents Corporation Announces Management Changes	04/19/04	CI
Cytosorbents Corporation Announces Executive Changes	30/17/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cytosorbents Corporation

Equities

CTSO

US23283X2062

Insiders

Filters